TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Coagulation Factor XI Market, Global Outlook and Forecast 2023-2030

Coagulation Factor XI Market, Global Outlook and Forecast 2023-2030

  • Category:Life Sciences
  • Published on : 29 October 2023
  • Pages :62
  • Formats:
  • Report Code:SMR-7840745

This report aims to provide a comprehensive presentation of the global market for Coagulation Factor XI, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coagulation Factor XI. This report contains market size and forecasts of Coagulation Factor XI in global, including the following market information:
Global Coagulation Factor XI Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Coagulation Factor XI market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
MR-1007 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Coagulation Factor XI include Bayer AG, Bristol-Myers Squibb Company, Cambryn Biologics LLC, eXithera Pharmaceuticals, Inc, Ionis Pharmaceuticals, Inc. and LegoChem Biosciences, Inc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Coagulation Factor XI companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Coagulation Factor XI Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Coagulation Factor XI Market Segment Percentages, by Type, 2022 (%)
MR-1007
IONIS-FXIRx
EP-7041
AB-022
BMS-262084
Others
Global Coagulation Factor XI Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Coagulation Factor XI Market Segment Percentages, by Application, 2022 (%)
Thrombosis
Bleeding and Clotting Disorders
Acute Ischemic Stroke
Others
Global Coagulation Factor XI Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Coagulation Factor XI Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Coagulation Factor XI revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Coagulation Factor XI revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer AG
Bristol-Myers Squibb Company
Cambryn Biologics LLC
eXithera Pharmaceuticals, Inc
Ionis Pharmaceuticals, Inc.
LegoChem Biosciences, Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Coagulation Factor XI, market overview.
Chapter 2: Global Coagulation Factor XI market size in revenue.
Chapter 3: Detailed analysis of Coagulation Factor XI company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Coagulation Factor XI in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Coagulation Factor XI Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Coagulation Factor XI Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Coagulation Factor XI Overall Market Size
2.1 Global Coagulation Factor XI Market Size: 2022 VS 2030
2.2 Global Coagulation Factor XI Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Coagulation Factor XI Players in Global Market
3.2 Top Global Coagulation Factor XI Companies Ranked by Revenue
3.3 Global Coagulation Factor XI Revenue by Companies
3.4 Top 3 and Top 5 Coagulation Factor XI Companies in Global Market, by Revenue in 2022
3.5 Global Companies Coagulation Factor XI Product Type
3.6 Tier 1, Tier 2 and Tier 3 Coagulation Factor XI Players in Global Market
3.6.1 List of Global Tier 1 Coagulation Factor XI Companies
3.6.2 List of Global Tier 2 and Tier 3 Coagulation Factor XI Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Coagulation Factor XI Market Size Markets, 2022 & 2030
4.1.2 MR-1007
4.1.3 IONIS-FXIRx
4.1.4 EP-7041
4.1.5 AB-022
4.1.6 BMS-262084
4.1.7 Others
4.2 By Type - Global Coagulation Factor XI Revenue & Forecasts
4.2.1 By Type - Global Coagulation Factor XI Revenue, 2018-2023
4.2.2 By Type - Global Coagulation Factor XI Revenue, 2024-2030
4.2.3 By Type - Global Coagulation Factor XI Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Coagulation Factor XI Market Size, 2022 & 2030
5.1.2 Thrombosis
5.1.3 Bleeding and Clotting Disorders
5.1.4 Acute Ischemic Stroke
5.1.5 Others
5.2 By Application - Global Coagulation Factor XI Revenue & Forecasts
5.2.1 By Application - Global Coagulation Factor XI Revenue, 2018-2023
5.2.2 By Application - Global Coagulation Factor XI Revenue, 2024-2030
5.2.3 By Application - Global Coagulation Factor XI Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Coagulation Factor XI Market Size, 2022 & 2030
6.2 By Region - Global Coagulation Factor XI Revenue & Forecasts
6.2.1 By Region - Global Coagulation Factor XI Revenue, 2018-2023
6.2.2 By Region - Global Coagulation Factor XI Revenue, 2024-2030
6.2.3 By Region - Global Coagulation Factor XI Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Coagulation Factor XI Revenue, 2018-2030
6.3.2 US Coagulation Factor XI Market Size, 2018-2030
6.3.3 Canada Coagulation Factor XI Market Size, 2018-2030
6.3.4 Mexico Coagulation Factor XI Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Coagulation Factor XI Revenue, 2018-2030
6.4.2 Germany Coagulation Factor XI Market Size, 2018-2030
6.4.3 France Coagulation Factor XI Market Size, 2018-2030
6.4.4 U.K. Coagulation Factor XI Market Size, 2018-2030
6.4.5 Italy Coagulation Factor XI Market Size, 2018-2030
6.4.6 Russia Coagulation Factor XI Market Size, 2018-2030
6.4.7 Nordic Countries Coagulation Factor XI Market Size, 2018-2030
6.4.8 Benelux Coagulation Factor XI Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Coagulation Factor XI Revenue, 2018-2030
6.5.2 China Coagulation Factor XI Market Size, 2018-2030
6.5.3 Japan Coagulation Factor XI Market Size, 2018-2030
6.5.4 South Korea Coagulation Factor XI Market Size, 2018-2030
6.5.5 Southeast Asia Coagulation Factor XI Market Size, 2018-2030
6.5.6 India Coagulation Factor XI Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Coagulation Factor XI Revenue, 2018-2030
6.6.2 Brazil Coagulation Factor XI Market Size, 2018-2030
6.6.3 Argentina Coagulation Factor XI Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Coagulation Factor XI Revenue, 2018-2030
6.7.2 Turkey Coagulation Factor XI Market Size, 2018-2030
6.7.3 Israel Coagulation Factor XI Market Size, 2018-2030
6.7.4 Saudi Arabia Coagulation Factor XI Market Size, 2018-2030
6.7.5 UAE Coagulation Factor XI Market Size, 2018-2030
7 Coagulation Factor XI Companies Profiles
7.1 Bayer AG
7.1.1 Bayer AG Company Summary
7.1.2 Bayer AG Business Overview
7.1.3 Bayer AG Coagulation Factor XI Major Product Offerings
7.1.4 Bayer AG Coagulation Factor XI Revenue in Global Market (2018-2023)
7.1.5 Bayer AG Key News & Latest Developments
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Company Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company Coagulation Factor XI Major Product Offerings
7.2.4 Bristol-Myers Squibb Company Coagulation Factor XI Revenue in Global Market (2018-2023)
7.2.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.3 Cambryn Biologics LLC
7.3.1 Cambryn Biologics LLC Company Summary
7.3.2 Cambryn Biologics LLC Business Overview
7.3.3 Cambryn Biologics LLC Coagulation Factor XI Major Product Offerings
7.3.4 Cambryn Biologics LLC Coagulation Factor XI Revenue in Global Market (2018-2023)
7.3.5 Cambryn Biologics LLC Key News & Latest Developments
7.4 eXithera Pharmaceuticals, Inc
7.4.1 eXithera Pharmaceuticals, Inc Company Summary
7.4.2 eXithera Pharmaceuticals, Inc Business Overview
7.4.3 eXithera Pharmaceuticals, Inc Coagulation Factor XI Major Product Offerings
7.4.4 eXithera Pharmaceuticals, Inc Coagulation Factor XI Revenue in Global Market (2018-2023)
7.4.5 eXithera Pharmaceuticals, Inc Key News & Latest Developments
7.5 Ionis Pharmaceuticals, Inc.
7.5.1 Ionis Pharmaceuticals, Inc. Company Summary
7.5.2 Ionis Pharmaceuticals, Inc. Business Overview
7.5.3 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Major Product Offerings
7.5.4 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Revenue in Global Market (2018-2023)
7.5.5 Ionis Pharmaceuticals, Inc. Key News & Latest Developments
7.6 LegoChem Biosciences, Inc
7.6.1 LegoChem Biosciences, Inc Company Summary
7.6.2 LegoChem Biosciences, Inc Business Overview
7.6.3 LegoChem Biosciences, Inc Coagulation Factor XI Major Product Offerings
7.6.4 LegoChem Biosciences, Inc Coagulation Factor XI Revenue in Global Market (2018-2023)
7.6.5 LegoChem Biosciences, Inc Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Coagulation Factor XI Market Opportunities & Trends in Global Market
Table 2. Coagulation Factor XI Market Drivers in Global Market
Table 3. Coagulation Factor XI Market Restraints in Global Market
Table 4. Key Players of Coagulation Factor XI in Global Market
Table 5. Top Coagulation Factor XI Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Coagulation Factor XI Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Coagulation Factor XI Revenue Share by Companies, 2018-2023
Table 8. Global Companies Coagulation Factor XI Product Type
Table 9. List of Global Tier 1 Coagulation Factor XI Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Coagulation Factor XI Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Coagulation Factor XI Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Coagulation Factor XI Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Coagulation Factor XI Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Coagulation Factor XI Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Coagulation Factor XI Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Coagulation Factor XI Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Coagulation Factor XI Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Coagulation Factor XI Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Coagulation Factor XI Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Coagulation Factor XI Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Coagulation Factor XI Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Coagulation Factor XI Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Coagulation Factor XI Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Coagulation Factor XI Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Coagulation Factor XI Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Coagulation Factor XI Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Coagulation Factor XI Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Coagulation Factor XI Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Coagulation Factor XI Revenue, (US$, Mn), 2024-2030
Table 30. Bayer AG Company Summary
Table 31. Bayer AG Coagulation Factor XI Product Offerings
Table 32. Bayer AG Coagulation Factor XI Revenue (US$, Mn) & (2018-2023)
Table 33. Bayer AG Key News & Latest Developments
Table 34. Bristol-Myers Squibb Company Company Summary
Table 35. Bristol-Myers Squibb Company Coagulation Factor XI Product Offerings
Table 36. Bristol-Myers Squibb Company Coagulation Factor XI Revenue (US$, Mn) & (2018-2023)
Table 37. Bristol-Myers Squibb Company Key News & Latest Developments
Table 38. Cambryn Biologics LLC Company Summary
Table 39. Cambryn Biologics LLC Coagulation Factor XI Product Offerings
Table 40. Cambryn Biologics LLC Coagulation Factor XI Revenue (US$, Mn) & (2018-2023)
Table 41. Cambryn Biologics LLC Key News & Latest Developments
Table 42. eXithera Pharmaceuticals, Inc Company Summary
Table 43. eXithera Pharmaceuticals, Inc Coagulation Factor XI Product Offerings
Table 44. eXithera Pharmaceuticals, Inc Coagulation Factor XI Revenue (US$, Mn) & (2018-2023)
Table 45. eXithera Pharmaceuticals, Inc Key News & Latest Developments
Table 46. Ionis Pharmaceuticals, Inc. Company Summary
Table 47. Ionis Pharmaceuticals, Inc. Coagulation Factor XI Product Offerings
Table 48. Ionis Pharmaceuticals, Inc. Coagulation Factor XI Revenue (US$, Mn) & (2018-2023)
Table 49. Ionis Pharmaceuticals, Inc. Key News & Latest Developments
Table 50. LegoChem Biosciences, Inc Company Summary
Table 51. LegoChem Biosciences, Inc Coagulation Factor XI Product Offerings
Table 52. LegoChem Biosciences, Inc Coagulation Factor XI Revenue (US$, Mn) & (2018-2023)
Table 53. LegoChem Biosciences, Inc Key News & Latest Developments
List of Figures
Figure 1. Coagulation Factor XI Segment by Type in 2022
Figure 2. Coagulation Factor XI Segment by Application in 2022
Figure 3. Global Coagulation Factor XI Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Coagulation Factor XI Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Coagulation Factor XI Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Coagulation Factor XI Revenue in 2022
Figure 8. By Type - Global Coagulation Factor XI Revenue Market Share, 2018-2030
Figure 9. By Application - Global Coagulation Factor XI Revenue Market Share, 2018-2030
Figure 10. By Type - Global Coagulation Factor XI Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Coagulation Factor XI Revenue Market Share, 2018-2030
Figure 12. By Application - Global Coagulation Factor XI Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Coagulation Factor XI Revenue Market Share, 2018-2030
Figure 14. By Region - Global Coagulation Factor XI Revenue Market Share, 2018-2030
Figure 15. By Country - North America Coagulation Factor XI Revenue Market Share, 2018-2030
Figure 16. US Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Coagulation Factor XI Revenue Market Share, 2018-2030
Figure 20. Germany Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 21. France Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Coagulation Factor XI Revenue Market Share, 2018-2030
Figure 28. China Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 32. India Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Coagulation Factor XI Revenue Market Share, 2018-2030
Figure 34. Brazil Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Coagulation Factor XI Revenue Market Share, 2018-2030
Figure 37. Turkey Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Coagulation Factor XI Revenue, (US$, Mn), 2018-2030
Figure 41. Bayer AG Coagulation Factor XI Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bristol-Myers Squibb Company Coagulation Factor XI Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Cambryn Biologics LLC Coagulation Factor XI Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. eXithera Pharmaceuticals, Inc Coagulation Factor XI Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Ionis Pharmaceuticals, Inc. Coagulation Factor XI Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. LegoChem Biosciences, Inc Coagulation Factor XI Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

Offer REPORT BUYING OPTIONS

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount